CAS 933041-13-5

Formula: C4H2BrClN2O

InChI: InChI=1S/C4H2BrClN2O/c5-2-1-3(6)7-8-4(2)9/h1H,(H,8,9)

InChI key: YUPQAGSTMGZXNO-UHFFFAOYSA-N

SMILES: C1=C(C(=O)NN=C1Cl)Br

4-Bromo-6-Chloropyridazin-3(2H)-One

CAS: 933041-13-5

4-Bromo-6-Chloropyridazin-3(2H)-One

Formula: C₄H₂BrClN₂O

Purity: >97%

Molecular weight: 209.43

Ref: 54-OR1011464

4-Bromo-6-chloropyridazin-3(2H)-one

CAS: 933041-13-5

Formula: C₄H₂BrClN₂O

Purity: 98%

Color and Shape: Solid

Molecular weight: 209.4285

Ref: IN-DA006GUM

4-Bromo-6-chloropyridazin-3(2H)-one

CAS: 933041-13-5

4-Bromo-6-chloropyridazin-3(2H)-one

Formula: C₄H₂BrClN₂O

Purity: 97%

Molecular weight: 209.43

Ref: IN-DG223060

4-Bromo-6-chloropyridazin-3(2H)-one

CAS: 933041-13-5

Formula: C₄H₂BrClN₂O

Purity: 96%

Color and Shape: Solid

Molecular weight: 209.43

Ref: 10-F234039

4-Bromo-6-chloropyridazin-3(2H)-one

CAS: 933041-13-5

4-Bromo-6-chloropyridazin-3(2H)-one is a glycosylation inhibitor and nucleoside analog that can be used in the treatment of cancer. It inhibits the synthesis of deoxyribonucleotides from ribonucleotides by binding to the enzyme ribonucleotide reductase, which catalyzes the conversion of ribonucleotides to deoxynucleotides. 4-Bromo-6-chloropyridazin-3(2H)-one has been shown to inhibit glycosylation in rat liver cells. This drug also inhibits acetone and glycosidation, which are reactions that produce glucose from amino acids or carbohydrates. The crystallization process is also inhibited by this drug because it prevents the formation of nucleoside crystals, which are involved in DNA replication and cell division.

Formula: C₄H₂BrClN₂O

Purity: Min. 95%

Molecular weight: 209.43 g/mol

Ref: 3D-FB141632